GPNMB enhances bone regeneration by promoting angiogenesis and osteogenesis: Potential role for tissue engineering bone

Journal of Cellular Biochemistry

Volumn 114, Issue 12, 2013, Pages 2729-2737

  Hu, Xuefeng ^a   Zhang, Ping ^b   Xu, Zhenjie ^b   Chen, Hongdong ^b   Xie, Xin ^b,c  

^a Department of Ophthalmology   (China)

^b Institute of Integrated Medical Information (IMI)   (China)

^c NORTHWEST UNIVERSITY   (China)

Author keywords

ANGIOGENESIS; BONE GENERATION; FGFR 1; GPNMB; OSTEOGENESIS

Indexed keywords

3 [4 METHYL 2 (2 OXO 3 INDOLINYLMETHYLIDENYL) 3 PYRROLYL]PROPIONIC ACID; ALKALINE PHOSPHATASE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GLYCOPROTEIN NON METASTATIC MELANOMA PROTEIN B; MESSENGER RNA; OSTEOCALCIN; PROTEIN; RECOMBINANT GLYCOPROTEIN NON METASTATIC MELANOMA PROTEIN B; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE REGENERATION; BONE REMODELING; CAPILLARY TUBE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SKULL DEFECT; TISSUE ENGINEERING;

ANGIOGENESIS; BONE GENERATION; FGFR-1; GPNMB; OSTEOGENESIS;

ALKALINE PHOSPHATASE; BONE REGENERATION; CELL DIFFERENTIATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOCALCIN; OSTEOGENESIS; PHOSPHORYLATION; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; TISSUE ENGINEERING;

EID: 84885618025     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24621     Document Type: Article

References (33)

1. Abdelmagid SM, Barbe MF, Arango-Hisijara I, Owen TA, Popoff SN, Safadi FF,. 2006. Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function. J Cell Physiol 210: 26-37.
2. Abdelmagid SM, Barbe MF, Rico MC, Salihoglu S, Arango-Hisijara I, Selim AH, Anderson MG, Owen TA, Popoff SN, Safadi FF,. 2008. Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function. Exp Cell Res 314: 2334-2351.
3. Abdelmagid SM, Barbe MF, Hadjiargyrou M, Owen TA, Razmpour R, Rehman S, Popoff SN, Safadi FF,. 2010. Temporal and spatial expression of osteoactivin during fracture repair. J Cell Biochem 111: 295-309.
4. Ardi VC, Van den Steen PE, Opdenakker G, Schweighofer B, Deryugina EI, Quigley JP,. 2009. Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway. J Cell Biochem 284: 25854-25866.
5. Baumann K,. 2013. Development: Growing a blood vessel network. Nat Rev Mol Cell Biol 14: 127.
6. Cheung LW, Leung KW, Wong CK, Wong RN, Wong AS,. 2011. Ginsenoside-Rg1 induces angiogenesis via non-genomic crosstalk of glucocorticoid receptor and fibroblast growth factor receptor-1. Cardiovasc Res 89: 419-425.
7. Cinotti G, Corsi A, Sacchetti B, Riminucci M, Bianco P, Giannicola G,. 2013. Bone ingrowth and vascular supply in experimental spinal fusion with platelet-rich plasma. Spine 38: 385-391.
8. Cui Q, Dighe AS, Irvine J,. 2013. Combined angiogenic and osteogenic factor delivery for bone regenerative engineering. Curr Pharm Des 19: 3374-3383.
9. Du X, Xie Y, Xian CJ, Chen L,. 2012. Role of FGFs/FGFRs in skeletal development and bone regeneration. J Cell Physiol 227: 3731-3743.
10. Franceschi R,. 2012. A novel approach to regeneration of bone: Using focused ultrasound for the spatiotemporal patterning of angiogenic and osteogenic factors. Ann Arbor: Michigan University.
11. Götz W, Reichert C, Canullo L, Jäger A, Heinemann F,. 2012. Coupling of osteogenesis and angiogenesis in bone substitute healing-A brief overview. Ann Anat 194: 171-173.
12. Hamada Y, Egusa H, Kaneda Y, Hirata I, Kawaguchi N, Hirao T, Matsumoto T, Yao M, Daito K, Suzuki M,. 2007. Synthetic osteopontin-derived peptide SVVYGLR can induce neovascularization in artificial bone marrow scaffold biomaterials. Dent Mater J 26: 487-492.
13. Han S-W, Jung Y-K, Lee E-J, Park H-R, Kim G-W, Jeong J-H, Han M-S, Choi J-Y,. 2013. DICAM inhibits angiogenesis via suppression of AKT and p38 MAP kinase signaling. Cardiovasc Res 98: 73-82.
14. Herbert SP, Stainier DY,. 2011. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol 12: 551-564.
15. Huang YC, Kaigler D, Rice KG, Krebsbach PH, Mooney DJ,. 2005. Combined Angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20: 848-857.
16. Hunsaker FG, Cioffi DA, Amadio PC, Wright JG, Caughlin B,. 2002. The American academy of orthopaedic surgeons outcomes instruments normative values from the general population. J Bone Joint Surg Am 84: 208-215.
17. Jarzabek K, Wolczynski S, Lesniewicz R, Plessis G, Kottler M,. 2012. Evidence that FGFR1 loss-of-function mutations may cause variable skeletal malformations in patients with Kallmann syndrome. Adv Med Sci 57: 314-321.
18. Kanczler J, Oreffo R,. 2008. Osteogenesis and angiogenesis: The potential for engineering bone. Eur Cell Mater 15: 100-114.
19. Karsenty G, Wagner EF,. 2002. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2: 389-406.
20. Kazenwadel J, Secker GA, Betterman KL, Harvey NL,. 2012. In vitro assays using primary embryonic mouse lymphatic endothelial cells uncover key roles for FGFR1 signalling in lymphangiogenesis. PLoS ONE 7: e40497.
21. Kuan C-T, Wakiya K, Dowell JM, Herndon JE, Reardon DA, Graner MW, Riggins GJ, Wikstrand CJ, Bigner DD,. 2006. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme. Clin Cancer Res 12: 1970-1982.
22. Lee SH, Lee J, Jung MH, Lee YM,. 2013. Glyceollins, a novel class of soy phytoalexins, inhibit angiogenesis by blocking the VEGF and bFGF signaling pathways. Mol Nutr Food Res 57: 225-234.
23. Marie PJ,. 2012. Fibroblast growth factor signaling controlling bone formation. Gene 498: 1-4.
24. Marie PJ, Miraoui H, Sévère N,. 2012. FGF/FGFR signaling in bone formation: Progress and perspectives. Growth Factors 30: 117-123.
25. Metz RL, Patel PS, Hameed M, Bryan M, Rameshwar P,. 2007. Role of human HGFIN/nmb in breast cancer. Breast Cancer Res 9: R58.
26. Murakami M, Simons M,. 2008. Fibroblast growth factor regulation of neovascularization. Curr Opin Hematol 15: 215.
27. Portal-Núñez S, Lozano D, Esbrit P,. 2012. Role of angiogenesis on bone formation. Histol Histopathol 27: 559.
28. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M,. 2005. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16: 159-178.
29. Qu D, Li J, Li Y, Gao Y, Zuo Y, Hsu Y, Hu J,. 2011. Angiogenesis and osteogenesis enhanced by bFGF ex vivo gene therapy for bone tissue engineering in reconstruction of calvarial defects. J Biomed Mater Res A 96: 543-551.
30. Rose AA, Annis MG, Dong Z, Pepin F, Hallett M, Park M, Siegel PM,. 2010. ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties. PLoS ONE 5: e12093.
31. Safadi F, Xu J, Smock SL, Rico MC, Owen TA, Popoff SN,. 2001. Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts. J Cell Biochem 84: 12-26.
32. Shikano S, Bonkobara M, Zukas PK, Ariizumi K,. 2001. Molecular cloning of a dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparan sulfate proteoglycans. J Cell Biochem 276: 8125-8134.
33. Wang Y-Q, Miao Z-H,. 2013. Marine-derived angiogenesis inhibitors for cancer therapy. Mar Drugs 11: 903-933.